ArticleBone marrow transplantation2024

Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD.

Zahra Hudda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.